Insulin/DM Medications

short acting insulin onset

30-45 minutes

short acting insulin peak

2-3 hours

short acting insulin duration

3-6 hours

humulin R and novolin R are _____ insulin

short acting

rapid acting insulin onset

5-15 minutes

rapid acting insulin peak

1 hour

rapid acting insulin duration

2-4 hours

novolog (aspart), humalog (lispro), and glulisine (apidra) are _____ insulins

rapid acting

afrezza onset

12 minutes

afrezza peak

1 hour

afrezza duration

1.5-3 hours

intermediate acting insulin onset

2-4 hours

intermediate acting insulin peak

4-12 hours

intermediate acting insulin duration

12-18 hours

NPH (novolin N or humulin N) and lenteglulisine are _____ insulins

intermediate acting

long acting insulin onset

1-2 hours

long acting insulin peak

none

long acting insulin duration

18-24 hours

glargine (lantus), detemir (levemir), and degludec (tresiba) are _____ insulins

long acting

this insulin is usually given in 2 daily doses and requires a bedtime snack with protein/CHO

intermediate acting insulin

these insulins are considered basal

intermediate and long acting

metformin and glucophage are:

biguanides

this class of medication increases insulin sensitivity and decreases glucose production by the liver

biguanides

monitoring B12 and folate levels of patients on these classes of medications is recommended

biguanides and sulfonylureas

glipizide, glimepiride, diabeta, glynase, and glyburide are all:

sulfonylureas

this class of medication increases insulin secretion and carries the risk of hypoglycemia

sulfonylurea

semiglutides, diaglutide, tirzepatide, liraglutide, and exenatide are all:

GLP-1s

this class of medication causes delayed gastric emptying, increases feeling of fullness, and reduces appetite

GLP-1